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coronary arteries may exist, resulting in a dual source of
coronary perfusion. Stenoses or complete interruption
of the coronary arteries may be present with large seg-
ments of the myocardial vascular bed dependent on per-
fusion via the RV (RV-dependent coronary circulation).
A variety of surgical strategies are possible. Optimal
repair involves recruitment of the RV for pulmonary
perfusion and separation of the 2 circulations (biven-
tricular repair). Patients with an adequate-sized tricus-
pid valve and RV, or those deemed to have the potential
for growth to adequate size after promotion of ante-
grade flow, can undergo a biventricular repair by creat-
ing continuity between the RV and the main pulmonary
artery.1 Commonly, an aortopulmonary shunt is placed
temporarily to secure adequate pulmonary perfusion.2
When the RV is very small, a biventricular repair may
not be feasible. If significant coronary stenoses or inter-
ruptions are present, then RV decompression may result
in compromise of the coronary circulation and a biven-
P ulmonary atresia with intact ventricular septum(PA/IVS) is an anatomically heterogeneous congen-
ital cardiac anomaly. Surgical management depends on
variables such as tricuspid valve diameter, right ventric-
ular (RV) size, and coronary anatomy. Fistulous con-
nections between the small, hypertensive RV and the
Objective: Pulmonary atresia with intact ventricular septum is an
anatomically heterogeneous anomaly with a variety of surgical strate-
gies possible. We sought to compare the outcome of patients with a sin-
gle ventricle approach to those with a biventricular repair and to com-
pare outcome of patients with coronary abnormalities to those with
normal coronary arteries. Methods: A retrospective review of our surgi-
cal database revealed 67 patients with pulmonary atresia with intact
ventricular septum operated on between 1981 and 1998. Patients were
categorized on the basis of initial surgical strategy: strategy A, aor-
topulmonary shunt alone (n = 31); strategy B, right ventricular recruit-
ment (n = 32); strategy C, heart transplantation (n = 4). Tricuspid valve
size (Z-score) and coronary anatomy were determined. Right ventricu-
lar–coronary artery dependency was noted in 8 patients. Results: Overall
actuarial survivals at 1, 5, and 8 years were 82%, 76%, and 76%.
Mortality was highest in infancy (10 of 16 deaths). Outcome was equiv-
alent for all 3 strategies. There was no difference in tricuspid valve size
between survivors and nonsurvivors (mean Z-score –2.0 (2.5) vs –2.0
(1.9), P = .83). There was no difference in survival based on severity of
coronary abnormality. Only one third of patients had a successful biven-
tricular repair, and the tricuspid valve was significantly larger in these
than in patients who had Fontan operation (mean Z-score –0.53 [1.6],
range –3.5 to 1, versus mean Z-score –3.03 [2.7], range –5.5 to 0, P =
.002). Conclusions: Surgical outcome for patients born with pulmonary
atresia with intact ventricular septum is satisfactory. The strategies of
biventricular repair, single ventricle palliation, and heart transplanta-
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tricular repair is contraindicated.3,4 A strategy directed
toward single ventricle repair via a Fontan operation5,6
or heart transplantation7 are alternative treatment
options.
Overall outcome for PA/IVS has been poor. In a
study by the Congenital Heart Surgeons Society, sur-
vival to 4 years was only 64%.8 RV dependency for
coronary circulation was identified as an early risk fac-
tor. Presumably, a more selective approach to perfor-
mance of a biventricular repair and use of either the sin-
gle ventricle approach or heart transplantation may
result in improved outcome. Recently, good outcome
has been reported in patients who have undergone the
Fontan operation for severe hypoplasia of the RV with
or without significant coronary abnormalities.5,6 The
purpose of our study was to review our experience with
PA/IVS and (1) to compare the outcome of patients
with single ventricle approach with that of those with
biventricular repair and (2) to compare the outcome of
patients with coronary abnormalities with that of those
with normal coronary arteries.
Methods and patients
We retrospectively reviewed the cardiothoracic surgery
database at the Children’s Hospital of Philadelphia and found
67 patients with the diagnosis of PA/IVS operated on between
July 1981 and April 1998. The initial palliative operation was
performed in infancy at a median age of 3 days (range 1-50
days). Five patients had initial palliation at another institu-
tion; the others underwent initial palliative procedures as listed
in Table I.
Patients were categorized into 3 groups on the basis of the
initial surgical strategy:
Strategy A: Single ventricle pathway (n = 31, 46%).
Patients treated by strategy A were considered not to be can-
didates for neonatal RV recruitment and had an aortopul-
monary shunt alone as their initial source for pulmonary
blood flow. One patient in this group had excision of the tri-
cuspid valve and another had patch closure of the tricuspid
valve simultaneous with placement of the shunt.9
Strategy B: Biventricular repair pathway (n = 32,
48%). Patients treated by strategy B were considered to have
an appropriate-sized RV for recruitment and had an operation
that included RV outflow tract reconstruction in infancy. All
but 1 patient in this group had simultaneous creation of an
accessory source of pulmonary blood flow (aortopulmonary
shunt in 15; ductal infiltration with formalin in 16).
Strategy C: Transplant pathway (n = 4, 6%). Patients
treated by strategy C were considered to have serious coro-
nary abnormalities prohibiting use of their native heart for
reconstruction and underwent heart transplantation. The duc-
tus arteriosus was kept patent via alprostadil (prostaglandin)
infusion in 2 patients, and 2 had placement of an aortopul-
monary shunt.
Decisions concerning initial surgical strategy were based
on the clinical judgment of the attending cardiologist and sur-
geon using data obtained from echocardiography and angiog-
raphy. Because of the time span of the study and evolution of
understanding of this disease over the years, no uniform cri-
teria were applied to each patient in determining which type
of treatment strategy to undertake. Factors included subjec-
tive assessment of RV and tricuspid valve size, the presence
of a tripartite RV,10 and the severity of coronary involvement
(ie, fistulas, stenoses, or interruptions).
Although subjective judgment was used to evaluate for RV
size at the time of management decision for each patient, we
retrospectively reviewed the initial echocardiograms or
angiogram to measure the tricuspid valve anulus diameter, as
suggested by Hanley and associates.8 Tricuspid valve Z-score
(number of standard deviations of the diameter measurement
from the expected mean for body surface area) was deter-
mined for each patient. Patients who underwent strategy A had
on average a smaller tricuspid valve anulus than patients who
underwent strategy B; however, overlap was present (mean Z-
score –3.2 [2.5], range –7 to 1.5 vs mean Z-score –0.5 [1.6],
range –4 to 1.5, P < .001). Patients who underwent strategy C
had a similar tricuspid valve size to those who underwent
strategy A (mean Z-score –3.3 [2.1], range –5 to –1).
Coronary angiography was performed in infancy and data
were available for review in 65 patients (97%). Patients were
grouped on the basis of severity of coronary abnormalities:
grade 0, no abnormalities (n = 37, 57%); grade 1, RV–coro-
nary artery fistulas alone (n = 20, 31%); grade 2, RV–coro-
nary artery fistulas and important stenoses/interruptions (RV-
dependent coronary circulation) (n = 8, 12%). Smaller
tricuspid valve size was noted in patients with more severe
coronary abnormalities. Mean tricuspid valve Z-scores for
coronary grades 0, 1, and 2 were –1.6 [2.4], –2.4 [2.3], and
–3.2 [2.1], respectively.
Of the 67 patients, 48 (72%) had a “definitive” repair at
most recent follow-up, defined as (1) a 2-ventricle system
with the RV supplying the pulmonary circulation with mini-
mal or no shunt at atrial or arterial level, (2) a single ventri-
cle system after a Fontan operation, (3) a superior vena
cava–pulmonary connection with inferior vena caval return
Table I. Initial palliative operations
Procedure No. of patients
Right modified Blalock-Taussig shunt 20
RV outflow tract reconstruction + formalin-infiltrated 16
PDA
RV outflow tract reconstruction + shunt 14
Waterston shunt 7
Central shunt 3
Left modified Blalock-Taussig shunt 3
Pulmonary valvotomy + shunt 1
RV outflow tract reconstruction (no shunt) 1
PDA, Patent ductus arteriosus.
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directed across the tricuspid valve and ejected into the pul-
monary circulation via the RV and superior vena caval return
channeled directly to the pulmonary arteries bypassing the
RV (11⁄2-ventricle repair),11 or (4) a heart transplantation.
Additional procedures were performed before or at the time
of the definitive repair (Table II).
Survival curves were generated by means of the Kaplan-
Meier method. The Cox proportional hazards regression was
used to look for differences based on initial operative strategy
and coronary anatomy. The t test was used to assess for dif-
ferences in tricuspid valve Z-score between survivors and
nonsurvivors.
Results
Fifty-one patients survived the operation for PA/IVS
(Fig 1). Follow-up is 7.2 ± 6.2 years (median 5.3 years,
range 0.6-26 years).
Strategy A: Single ventricle pathway (n = 31).
Three infants did not survive beyond initial palliation
(early mortality of 9%) (Fig 2). One had a dilated RV
with dysplastic tricuspid valve, 1 had RV-dependent
coronary circulation (coronary grade 2) with interrup-
tion of the left anterior descending coronary artery and
died suddenly at home 6 weeks after aortopulmonary
shunt, and 1 infant with coronary fistulas alone (coro-
nary grade 1) died suddenly 1 week after aortopul-
monary shunt of unexplained causes (procedure per-
formed before 1985). Of the 28 survivors, 19 (58%)
advanced to the Fontan operation at a median age of 24
months (range 14-215 months) with 1 early death relat-
ed to low cardiac output (normal coronary arteries) and
no late deaths.
Four patients had an initial aortopulmonary shunt
placed before 1986 and had late (3-4 years of age) suc-
cessful recruitment of the RV and a biventricular repair
by creating continuity between the RV and pulmonary
artery. A prosthetic valved conduit (18 mm and 20 mm)
was used in 2, a pulmonary homograft in 1, and a pul-
monary valvotomy alone was performed in 1.
Four patients had a hemi-Fontan or bidirectional
Glenn shunt with 2 deaths. One had postoperative left
ventricular (LV) dysfunction and died (coronary grade
1), and 1 died in a motor vehicle accident. Two sur-
vivors are presently awaiting the Fontan operation.
One patient had a Waterston shunt placed in infancy,
was lost to follow-up, and appeared again with severe
LV dysfunction at 19 years of age (coronary grade 0).
The patient received a heart transplant but died of acute
postoperative graft failure.
Strategy B: Biventricular repair pathway (n = 32).
Early mortality was high, with 8 patients (25%) not
surviving beyond the initial operation (Fig 3). Two of
these had a dilated RV and right atrium with severe
dysplasia of the tricuspid valve, and 2 had evidence of
aortic/subaortic stenosis with a gradient of more than
30 mm Hg on catheterization or Doppler echocardiog-
raphy. No coronary abnormalities were present in these
patients. Death occurred within 1 to 5 days of the oper-
Table II. Additional procedures before or during
definitive repair
Procedure No. of patients
Hemi-Fontan/BDG 19
Relief of RVOT obstruction 9
Additional aortopulmonary shunt 7
Closure of ASD 5
Coil embolization of shunt 2
Balloon dilation of RVOT 2
Restriction of Waterston shunt 1
Banding of formalin-infiltrated PDA 1
Clipping of shunt 1
ASD, Atrial septal defect; BDG, bidirectional Glenn; RVOT, right ventricular
outflow tract; PDA, patent ductus arteriosus.
Fig 1. Actuarial survival curve for all 67 patients. Numbers in
parentheses designate the number of patients. Dashed lines
represent 70% confidence limits.
Fig 2. Flow chart of outcome for patients who underwent
strategy A. a, Alive; d, dead; BDG, bidirectional Glenn; Bi-
Vent, biventricular repair; hF, hemi-Fontan operation.
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ation. Another infant had normal coronary arteries, a
bicuspid, stenotic aortic valve with a 50 mm Hg gradi-
ent on catheterization, and underwent a balloon dilation
of the aortic valve. Progressive biventricular failure
ensued and the infant received a heart transplant at 4
months of age but died of multisystem organ failure.
Three infants died within 1 week of the operation of
unexplained causes; 2 had coronary fistulas with no
evidence for stenoses (coronary grade 1), and in 1
angiographic data were unavailable.
Of the 24 survivors of the initial operation, 18 (75%)
had a successful biventricular repair with no deaths; 2
had placement of a superior vena cava–pulmonary con-
nection and closure of the interatrial communication
with no deaths (11⁄2-ventricle repair).
Three patients were switched to a single ventricle
approach. One had an initial pulmonary valvotomy
with multiple aortopulmonary shunts placed early in
life and was referred late to our institution with
cyanosis and a small RV. A hemi-Fontan operation was
performed at age 16 followed by a Fontan operation 6
months later. Another patient had poor growth of the
RV and had a Fontan operation at 18 months of age.
Another patient had poor growth of the RV, LV dys-
function (coronary grade 1), and underwent a hemi-
Fontan operation followed by a Fontan operation 6
months later. LV dysfunction persisted and he under-
went successful heart transplantation 5 months later.
Strategy C: Transplant pathway (n = 4). Four
patients had serious coronary abnormalities (grade 2) in
infancy and were listed for heart transplantation (Fig 4).
One infant had a cardiac arrest while awaiting trans-
plantation and subsequently died early after receiving a
heart transplant as a result of multisystem organ failure.
The other is well from a cardiac standpoint 7 years after
transplantation but has lymphoproliferative disease. The
2 patients who had placement of an aortopulmonary
shunt were discharged to their homes and received
transplants at 31⁄2 and 51⁄2 months of age, respectively.
One was re-listed for transplantation because of devel-
opment of severe mitral regurgitation, obtained a heart
11 months after the original transplant, and is doing
well at 34 months of age. The other is doing well at 32
months of age.
Surgical strategy, coronary anatomy, tricuspid
valve size, and survival. There was no difference in
survival on the basis of surgical strategy (P = .52) (Fig
5) or coronary anatomy (P = .22). Excluding the 3
patients who had a dilated right atrium and ventricle,
all of whom died, there was no difference in tricuspid
valve Z-score between survivors and nonsurvivors
(–2.0 [2.5] vs –2.0 [1.9], P = .83). However, the tricus-
pid valve anulus was significantly larger in the patients
who had successful biventricular repair than in those
who underwent a successful Fontan operation (mean Z-
score –0.53 [1.6], range –3.5 to 1, vs mean Z-score
–3.03 [2.7], range –5.5 to 0, P = .002).
Discussion
A biventricular repair may not be suitable for all
patients with PA/IVS. RV size and coronary anatomy
dictate the tailoring of an individual strategy for each
patient.12-14 In our series, biventricular repair was
achieved in only one third of patients. None had RV-
dependent coronary circulation and, similar to the find-
ings of the Congenital Heart Surgeons Society study,
all had a tricuspid valve Z-score greater than –4.8 The
application of single ventricle palliation or heart trans-
plantation strategies allow for equivalent outcomes to
be achieved even in patients with the risk factors of
small RV size and coronary abnormality.
Although the primary disease is in the RV, it is the LV
Fig 3. Flow chart of outcome for patients who underwent
strategy B.
Fig 4. Flow chart of outcome for patients who under-
went strategy C. PDA, Patent ductus arteriosus; PGE, prosta-
glandin E.
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myocardium that is vulnerable to circulatory insuffi-
ciency and dysfunction. Ischemia can occur if decom-
pression of the RV is attempted when a large portion of
the myocardium is supplied by a hypertensive RV with
coronary stenoses just proximal to the connecting site
between the RV and coronary artery (RV-coronary
dependency).4 Even in the absence of proximal sten-
oses, when there is dual supply to the coronary arteries
from both the RV and aorta, decompression of the RV
may result in a “steal” of coronary blood into the RV,
with diminished perfusion to areas distal to the con-
nection.3 Focal narrowing and diffuse hypoplasia of the
coronary arteries distal to the connecting site to the RV
have also been described, implying that a competitive
source of coronary flow results in the development of
an abnormal vascular tree downstream from the initial
lesion.15 Functional disturbances including abnormali-
ties of LV regional wall motion, LV compliance, and
systolic performance have been demonstrated even in
patients with less severe coronary abnormalities.16-18
Recent data support the view that histologic abnormal-
ities of the LV are present in all patients with PA/IVS
who do not have a normal-sized RV and completely
normal coronary arteries. Akiba and Becker19 found
increased myocardial cell swelling and increased inter-
fiber collagen content, reflecting chronic ischemia in
unoperated specimens from patients with PA/IVS and
Fig 5. Actuarial survival curves for patients who underwent
single ventricle strategy (A) and biventricular repair strategy
(B). Survival for the 2 strategies is similar (P = .52, Cox pro-
portional hazards). Numbers in parentheses designate the
number of patients. Dashed lines represent 70% confidence
limits.
Fig 6. Actuarial survival curves based on normal coronary
anatomy (A), RV-coronary fistulas alone (B), and RV-depen-
dent coronary circulation (C). There was no difference in sur-
vival (P = .22, Cox proportional hazards). Numbers in paren-
theses designate the number of patients. Dashed lines
represent 70% confidence limits.
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no coronary stenoses. They concluded that these find-
ings make the LV less tolerant of potential volume
loads.
This observation may in part explain the high early
mortality in this study; 63% of our deaths occurred
within the first 2 weeks after initial palliation. Aorto-
pulmonary shunt placement results in a volume load on
the LV and a lowering of systemic diastolic pressure.
The workload on the heart is increased while coronary
perfusion is diminished in infants with a vulnerable
myocardium. In particular, excessive pulmonary over-
circulation may have been present in those with a for-
malin-infiltrated ductus because accurately constricting
the ductus arteriosus can be difficult and imprecise.20 In
addition, severe coronary abnormalities may have been
overlooked. Aortography and RV angiography were
used to determine coronary anatomy; however, in the
absence of selective coronary injections, a difficult and
high-risk procedure in neonates, important stenoses
may be missed.
Six patients had unique anatomy that may have con-
tributed to their early deaths. Massive dilatation of the
right atrium and RV were noted in 3 infants with a dys-
plastic, incompetent tricuspid valve, although only 1 of
these had a clear Epstein malformation with apical dis-
placement of the tricuspid valve septal leaflet.21
Hemodynamically significant anatomic obstruction to
LV outflow was present in 3 other patients. Septal bow-
ing and LV outflow obstruction after the Fontan opera-
tion has been described22; however, the finding of sig-
nificant aortic valve or fixed subaortic narrowing is
unusual and not previously reported.
In our series, 7 patients underwent heart transplanta-
tion. Whether to use the strategy of heart replacement
at the outset or to plan for a single ventricle approach
in patients with RV-dependent coronary circulation is
unclear. Some have argued that quantifying the degree
of RV-coronary dependency is useful and that RV
decompression can be successfully achieved if no more
than 1 coronary vessel is involved.4 As previously stat-
ed, accurately defining the precise coronary anatomy in
a neonate can be difficult. Adequate myocardial perfu-
sion in the presence of RV-coronary dependency, or
even a fistulous connection alone with dual distal sup-
ply, does not guarantee continuing good perfusion over
time. Shear forces from RV ejection into the coronary
vessel may result in a progressive obliterative process
at the site of connection.15 In addition, until the time of
separation of the circulations at the Fontan operation,
the RV is ejecting desaturated blood into the coronary
arteries, which may place the distal myocardium at risk
for ischemia, in particular during periods of high
demand. When deciding on a single ventricle strategy
or heart replacement, one must weigh these concerns
against the issues of organ availability, early graft fail-
ure, rejection, and coronary graft disease after heart
transplantation.7
To date, there is little data on the well-being of
patients with severe coronary abnormalities after the
Fontan operation. In our series, only 2 patients with
RV-coronary dependency had a Fontan operation, and 1
is awaiting the Fontan operation, all without overt clin-
ical evidence for myocardial ischemia. In addition, all
12 patients with fistulas alone between the RV and
coronary arteries (grade 1) who survived beyond the
Fontan procedure are doing well at a median of 56
months. Of note, none of these patients had thrombo-
exclusion of the RV, as recommended by some,23 and
only 1 had excision of the tricuspid valve, which sub-
sequently resulted in ischemia and an apical aneurysm
of the LV. Whether myocardial insufficiency will develop
over time is unclear. Sensitive methods for detecting
progressive changes in myocardial perfusion such as
thallium imaging studies or dobutamine-stress echocar-
diography may prove useful when used serially in these
patients.24,25 A combined approach involving the single
ventricle strategy initially, with listing for heart trans-
plantation at the early signs of myocardial insuffi-
ciency, may be the best approach. If the single ventri-
cle approach is chosen, we recommend the placement
of a small aortopulmonary shunt to limit pulmonary
blood flow and the early performance of a superior
vena cava–pulmonary connection to eliminate volume
load and improve diastolic coronary filling. Early per-
formance of the Fontan operation should also be con-
sidered to divert pulmonary venous return to the RV at
the earliest opportunity, thereby allowing for fully sat-
urated blood to be ejected into the coronary arteries.
We acknowledge the cardiac surgeons who have cared for
the infants and children with pulmonary atresia and intact
ventricular septum at our institution over the span of this
study: A. Aberdeen, L. Stephenson, L. H. Edmunds, J. D. Pigott,
W. I. Norwood, and M. L. Jacobs. In addition, we acknowl-
edge the technical assistance of Rita Novello in collecting the
data on tricuspid valve diameter and calculating the Z-scores.
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Discussion
Dr Mohan V. Reddy (San Francisco, Calif). I congratulate
Dr Rychik and his group on their excellent results in this dif-
ficult group of patients. 
PA/IVS is a heterogenous lesion in terms of RV morphology.
The RV can vary from a diminutive to a dilated RV, which is
essentially nonfunctional. The literature is replete with
numerous reports of outcomes with different strategies.
Because of that, I think one of the important outcomes of the
multi-institutional study was to identify certain factors asso-
ciated with early or late outcomes. to that effect, the Con-
genital Heart Surgeons Study has shown that biventricular
repair is unsuccessful in patients who have a tricuspid valve
Z-factor of less than 3. 
In your own experience over a 15-year span, you have
shown essentially good results with subjective impression of
the surgeon and the cardiologist; however, you failed to
achieve a successful biventricular repair in patients with a tri-
cuspid valve Z-value of less than –3.5. Do you presently use
the tricuspid valve Z-value as a criterion for initial strategy in
the treatment of these patients? 
Second, after a patient receives a cavopulmonary shunt, do
you have any echocardiographic or computed tomographic
criteria to decide whether to attempt a Fontan repair, a partial
biventricular repair, or 11⁄2-ventricle repairs? 
My final question is this: In your large experience I failed
to notice any patients with Ebstein’s malformation of the tri-
cuspid valve. In our experience these patients have a very
poor prognosis. Have you treated such patients, and do you
consider them candidates for transplants? 
Dr Rychik. Thank you, Dr Reddy, for your comments. 
Regarding tricuspid valve size, the question frequently
comes up as to whether one should stick with a strict regimen
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of using tricuspid valve Z-score versus using one subjective
assessment of RV size. In my experience, and I think in the
experience of others, there appears to be fairly good concor-
dance between the two. Experienced surgeons and cardiolo-
gists are fairly good at determining when an RV is of ade-
quate size and when it is not. As you mentioned, the
Congenital Heart Surgeons Society used a cutoff of about –3
to –4, and our tricuspid valve Z-score when we looked back
at this retrospectively fell into that same category. 
What is still not completely clear are some of the other
variables that enter into the assessment subjectively as to
whether an RV is of adequate size. Other authors have used
the concept of the different parts of the RV, for example,
whether the RV is tripartite with an infundibular sinus portion
and trabecular zone. 
At the moment we would still probably stick with a subjec-
tive assessment. We would evaluate the tricuspid valve diam-
eter as part of the complete evaluation, looking at the different
parts of the RV as well, to determine whether there was an
infundibular outflow, sinus portion, or trabecular zone. 
Your second question concerned our use of criteria to deter-
mine whether we should proceed to a biventricular repair or
not. We take these patients to the catheterization laboratory
and attempt to close or balloon occlude the atrial septum and
assess for right atrial pressures and mixed venous saturation
to estimate for cardiac output.
Regarding the tricuspid valve, some patients clearly have
Ebstein’s anomaly of the tricuspid valve. At times it can be
difficult to determine in that category of patients whether one
is dealing with a functional pulmonary atresia or in fact
anatomic atresia. That is a different category of patients from
the 2 or 3 in this study who, by strict anatomic definition, did
not seem to have Ebstein’s anomaly. As an echocardiographer,
I would describe Ebstein’s anomaly as inferior and apical dis-
placement of the septal leaf of the tricuspid valve with a long
curtain-like anterior leaflet. These patients did not fall into
that category. They had evidence for very thickened dysplas-
tic-appearing tricuspid valves without displacement of the
septal leaflet. Those patients have a primary tricuspid valve
abnormality that results in poor anterograde flow prenatally
and then results in pulmonary atresia; however, they may very
well be a different group of patients. Physiologically, the RV
in those patients is similar to that of the patients with Ebstein’s
anomaly. They have very poor potential for development of
forward flow, and I think they should be considered for heart
transplantation.
Authoritative
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